Date Posted: Feb 9, 2018
Application Deadline: Mar 11, 2018
A post-doctoral fellow position is immediately available in the Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center. The successful applicant will join an interdisciplinary team to develop high-throughput functional screen platforms using CRISPR Cas9 or dCas9 systems, and to apply the platforms for the studies of cancer epigenetics and drug discovery. Potential research directions include but are not limited to: i) identifying cancer regulators involved in drug resistance; ii) identifying functional protein domains of epigenetic regulators as therapeutic targets; iii) genome-scale functional analysis of non-coding regulatory elements in cancer cells. The candidate must have a recent Ph.D. or M.D./Ph.D in biomedical science, preferably in biochemistry or molecular biology. The candidate must have a first-authored publication in a highly regarded scientific journal, demonstrated ability of independent research, and proven proficiency in written and spoken English. Experience and knowledge in CRISPR techniques, high-throughput sequencing, or epigenetics will be an advantage. This position is located at the Science Park campus in Smithville, Texas, and will be co-supervised by experts in bioinformatics and experimental biology. To apply, please send a cover letter, CV, statement of research interest and contact information of 2-3 references via email to: email@example.com, Han Xu, Ph.D.
M. D. Anderson Cancer Center is an equal opportunity employer and does not discriminate on basis of race, color, national origin, gender, sexual orientation, age, religion, disability or veteran status except where such distinction is required by law. All positions at The University of Texas M. D. Anderson Cancer Center are security sensitive and subject to examination of criminal history record information. Smoke-free and drug-free environment.